Suchergebnisse

This exposé investigates the evolution of the Almighty Black P Stone Nation, a motley group of poverty-stricken teens transformed into a dominant gang accused of terroristic intentions. Interwoven into the narrative is the dynamic influence of leader Jeff Fort, who-despite his flamboyance and high visibility-instilled a rigid structure and discipline that afforded the young men a refuge and a sense of purpose in an often hopeless community. Details of how the Nation procured government funding for gang-related projects during the War on Poverty era and fueled bonuses and job security for law e

This exposé investigates the evolution of the Almighty Black P Stone Nation, a motley group of poverty-stricken teens transformed into a dominant gang accused of terroristic intentions. Interwoven into the narrative is the dynamic influence of leader Jeff Fort, who -- despite his flamboyance and high visibility -- instilled a rigid structure and discipline that afforded the young men a refuge and a sense of purpose in an often hopeless community. Details of how the Nation procured government funding for gang-related projects during the War on Poverty era and fueled bonuses and job security for law enforcement, and how Fort, in particular, masterminded a deal for $2.5 million to commit acts of terrorism in the United States on behalf of Libya are also revealed. In examining whether the Black P Stone Nation was a group of criminals, brainwashed terrorists, victims of their circumstances, or champions of social change, this social history provides an exploration of how and why gangs flourish and insight into the way in which minority crime is targeted in the community, reported in the media, and prosecuted in the courts.

The Society of Behavioral Medicine (SBM) supports the United States Preventive Services Task Force (USPSTF) recommendation of low-dose computed tomography (LDCT) screening of the chest for eligible populations to reduce lung cancer mortality. Consistent with efforts to translate research findings into real-world settings, SBM encourages health-care providers and health-care systems to (1) integrate evidence-based tobacco treatment as an essential component of LDCT-based lung cancer screening, (2) examine the structural barriers that may impact screening uptake, and (3) incorporate shared decision-making as a clinical platform to facilitate consultations and engagement with individuals at high risk for lung cancer about the potential benefits and harms associated with participation in a lung cancer screening program. We advise policy makers and legislators to support screening in high-risk populations by continuing to (1) expand access to high quality LDCT-based screening among underserved high-risk populations, (2) enhance cost-effectiveness by integrating evidence-based tobacco treatments into screening in high-risk populations, and (3) increase funding for research that explores implementation science and increased public awareness and access of diverse populations to participate in clinical and translational research.